MOR202 with Low-Dose Dexamethasone (Dex) or Pomalidomide/Dex or Lenalidomide/Dex in Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis of a Phase I/IIa, Multicenter, Dose-Escalation Study - Raab, Marc S.; Chatterjee, Manik; Goldschmidt, Hartmut; Agis, Hermine; Blau, Igor; Einsele, Hermann; Engelhardt, Monika; Ferstl, Barbara; Gramatzki, Martin; Rollig, Christoph; Weisel, Katja; Jarutat, Tiantom; et al. (BLOOD, 2018)
CRIS-Team WoS Importer:2019-03-06